Pharmacists are invited to contribute to a major new medication safety initiative
The Australian Commission on Safety and Quality in Health Care is seeking feedback on the draft of Australia’s national response to the third World Health Organization Global Patient Safety Challenge – Medication without harm.
In March 2017, the World Health Organization (WHO) launched the third Global Patient Safety Challenge (Challenge) with the theme of medication without harm. The goal of the Challenge is to gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years. The Australian Government made a commitment to participate in the Challenge, and the Commission is tasked with developing a national response.
The three focus areas of the Challenge are high-risk situations (high-risk medicines), polypharmacy and transitions of care. The high-risk medicines are anti-psychotics, insulin, opioids, heparin and anti-coagulants.
In Australia, the goal is to reduce medication errors, adverse drug events and medication-related hospital admissions by 50% by 2025. The Commission is seeking input from stakeholders with programs that address high-risk medicines, polypharmacy, and transitions of care.
More information on the focus areas can be found here.
To provide a response to the Challenge discussion paper please download and send a completed feedback form to email@example.com.
Consultation closes Friday 5 July 2019.